Quest Diagnostics (DGX) Change in Accured Expenses (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Change in Accured Expenses data on file, last reported at -$12.0 million in Q1 2026.

• Quarterly Change in Accured Expenses rose 77.36% year-over-year to -$12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $170.0 million (up 431.25% YoY) and the FY2025 annual result came in at $129.0 million, up 292.54% from the prior year.
• Change in Accured Expenses declined to -$12.0 million in Q1 2026 per DGX's latest filing, from $16.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $176.0 million in Q4 2023, with the low at -$211.0 million in Q1 2023.
• Average Change in Accured Expenses over 5 years is -$9.1 million, with a median of $16.0 million recorded in 2025.
• Year-over-year, Change in Accured Expenses jumped 2100.0% in 2022 and tumbled 334.38% in 2023.
• Quest Diagnostics' Change in Accured Expenses stood at $20.0 million in 2022, then surged by 780.0% to $176.0 million in 2023, then sank by 80.11% to $35.0 million in 2024, then sank by 54.29% to $16.0 million in 2025, then slumped by 175.0% to -$12.0 million in 2026.
• Business Quant data shows DGX's Change in Accured Expenses at -$12.0 million in Q1 2026, $16.0 million in Q4 2025, and $124.0 million in Q3 2025.